知镜 Cognispect · 医学文献与研究工作台

Zoledronic Acid in the Management of Melorheostosis of Radius and Ulna - A Rare Case Report with Literature Review.

Mallya S, Das R, Boruah DK, Puranik A.
Journal of orthopaedic case reports · 2026-06-01 · PMID 42273437

文献摘要

Introduction Melorheostosis is an exceptionally rare mesodermal mixed sclerosing bone dysplasia that sometimes affects the surrounding soft tissue. There are no established guidelines for its management, as it is not a curable condition. Treatment primarily focuses on symptom relief and necessitates a coordinated multimodal approach involving orthopedics, physical medicine and rehabilitation, and pain management to achieve optimal results. Bisphosphonates have shown efficacy in this condition, alleviating pain and reducing disease severity. The literature contains only nine reports concerning the use of zoledronate in the treatment of melorheostosis. Case report We report a case involving a 24-year-old female diagnosed with melorheostosis affecting the radius and ulna, accompanied by subcutaneous hemangiomatosis, which was effectively managed with intravenous zoledronate and physiotherapy. Conclusion This case report emphasizes the key characteristics of melorheostosis, the involvement of soft-tissues in this condition, and the application of zoledronate in its treatment, while highlighting the need for and potential of future research in this area.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。